News About: Pharm. Industry
Drug export gains momentum in September
Korea’s drug exports showed a positive sign in September, while its producer’s shipment index declined.
The drug export shipment was 258.0 in September, up 14.9 percent from the same month of last year.
The cou...
Mvix is effective in once daily dosing for erectile dysfunction/positive BPH results
SK Chemicals announced that it has completed a 140 patient once-a-day dosing clinical study of mirodenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
A total of 1...
Concerns growing over cash incentive plan
There are mounting concerns over the whereabouts of the contentious cash incentive system, which took effect last November but was inevitably delayed for 1 year.
Still, the government shows a lukewarm attitude over...
CrystalGenomics gets U.S. patent on novel cancer candidate
CrystalGenomics, a high-flying Korean biotechnology venture, announced Friday in its regulatory filing that the U.S. Patent and Trademark Office issued the company a patent covering the investigational cancer candidat...
Pharmaceutical firms brace for specter of massive drug price cuts
Domestic drug firms are scrambling to slash their administrative and promotional expenses from the current 40 percent to 30 percent, as they are expected to face serious financial losses starting next year with the sp...
New drug pricing reform will hurt leading pharmaceutical firms
A report released on November 11 said Korea's eight leading drug makers could lose up to 765.5 billion won in revenue and 750.8 billion won in operating income by 2014 if the government’s drug price cut plan goes into...
7 pharmaceutical firms seek court action against measure designed to reduce insurance expenditures
Seven pharmaceutical firms have filed a lawsuit against the Education Ministry to nullify the government's decision to slash the price cut of their drugs involved in illegal rebate.
"We cannot let the current drug ...
Dong-A, Green Cross likely immune to financial crisis
Chances are looming larger that a majority of pharmaceutical firms, except for Dong-A Pharmaceutical and Green Cross Crop., will face a blow for their revenues as the government’s new drug pricing initiative could not...
Government to expand R&D spending
The Ministry of Health and Welfare unveiled its plan to support innovative pharmaceutical companies to be selected based on their research & development performance and potential for exports, according to the Korea Dr...
Restructuring to take shape in April
The country's pharmaceutical companies are planning massive restructuring measures, with many of them to be initiated in next April, as they look to respond to the government’s plan to cut drug prices by an average of...
